{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-022471","form_type":"8-K","ticker":"ELVN","cik":"0001672619","company_name":"Enliven Therapeutics, Inc.","filed_at":"2022-06-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.734540+00:00","generated_at":"2026-06-25T04:47:35.782116+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Imara Inc. reports annual meeting results; elects directors, ratifies EY as auditor","bullets":["Stockholders elected Rahul D. Ballal and Barbara J. Dalton as Class II directors for three-year terms expiring 2025.","Ballal received 11,789,401 votes for and 1,791,276 withheld; Dalton had 11,786,912 for and 1,793,765 withheld.","Ratification of Ernst & Young as independent auditor for FY 2022 passed with 18,806,373 votes for, 60,227 against, 46,749 abstentions.","Meeting held on June 2, 2022; broker non-votes on director elections totaled 5,332,673."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-022471","json":"https://secwatch.observer/filing/0001564590-22-022471.json","markdown":"https://secwatch.observer/filing/0001564590-22-022471.md","text":"https://secwatch.observer/filing/0001564590-22-022471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1672619/000156459022022471/0001564590-22-022471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1672619/000156459022022471/imra-8k_20220602.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T04:47:35.782116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}